Table. Characteristics and outcomes of mothers and babies infected with SARS-CoV-2.
Variable | n | % | [95% CI] |
Week of gestation when testing positive for SARS-CoV-2 | |||
< 22 + 0 22 + 0 to 27 + 6 28 + 0 to 31 + 6 32 + 0 to 36 + 6 ≥ 37 + 0 Not available |
54 26 25 51 83 8 |
21.9 10.5 10.1 20.6 33.6 3.2 |
[17.2; 27.4] [7.3; 15.0] [7.0; 14.5] [16.1; 26.1] [28.0; 39.7] [1.7; 6.3] |
Symptoms | |||
None Cough Malaise, chills Fatigue Loss of or change to sense of smell or taste Temperature > 38 °C Sore throat Nasal congestion Headache Dyspnea Myalgia Chest pain Productive cough Diarrhea Nausea, vomiting Dizziness, drowsiness Not available |
91 93 83 68 66 61 60 55 48 43 42 23 22 14 12 12 2 |
36.8 37.7 33.6 27.5 26.7 24.7 24.3 22.3 19.4 17.4 17.0 9.3 8.9 5.7 4.9 4.9 0.8 |
[31.1; 43.0] [31.8; 43.8] [28.0; 39.7] [22.3; 33.4] [21.6; 32.6] [19.7; 30.4] [19.4; 30.0] [17.5; 27.9] [15.0; 24.8] [13.2; 22.6] [12.8; 22.2] [6.3; 13.6] [6.0; 13.1] [3.4; 9.3] [2.8; 8.3] [2.8; 8.3] [0.1; 2.9] |
Outcomes in pregnant women regarding SARS-CoV-2/COVID-19 | |||
Currently recovered Inpatient admission Of which intensive care (ICU) Of which invasively ventilated Of which critical (ECMO, etc) Of which deceased Ongoing or lost to follow-up |
205 34 14 5 5 1 40 |
83.0 13.8 5.7 2.0 2.0 0.4 16.2 |
[77.8; 87.2] [10.0; 18.6] [3.4; 9.3] [0.9; 4.7] [0.9; 4.7] [0.0; 2.3] [12.1; 21.3] |
Obstetric pregnancy outcome | |||
Completed pregnancies Delivery of liveborn baby Delivery of stillborn baby Termination of pregnancy Ongoing or lost to follow-up |
189 183 2 4 58 |
76.5 74.1 0.8 1.6 23.5 |
[70.9; 81.4] [68.3; 79.2] [0.1; 2.9] [0.6; 4.1] [18.6; 29.1] |
Gestational age of liveborn babies (in weeks + days)* | |||
22 + 0 to 27 + 6 28 + 0 to 31 + 6 32 + 0 to 36 + 6 ≥ 37 + 0 Not available |
0 2 23 158 3 |
0.0 1.1 12.4 84.9 1.6 |
[0.0; 2.0] [0.2; 3.8] [8.4; 17.9] [79.1; 89.4] [0.4; 4.6] |
Mode of delivery* | |||
Spontaneous vaginal delivery Operative vaginal delivery Primary cesarean section Secondary cesarean section Emergency cesarean section Not available |
94 11 44 29 2 3 |
51.4 6.0 24.0 15.8 1.1 1.6 |
[44.0; 59.0] [3.4; 10.0] [18.0; 31.0] [11.0; 22.0] [0.2; 3.9] [0.4; 4.7] |
Neonatal outcome* | |||
Referral to neonatal intensive care unit (NICU) CPAP non-invasive ventilation Intubation / invasive ventilation SARS-CoV-2-PCR positive |
25 7 2 4 |
13.4 3.8 1.1 2.2 |
[9.3; 19.1] [1.8; 7.6] [0.2; 3.8] [0.8; 5.4] |
The rates refer to the entire CRONOS cohort and (*) live births, respectively.
CPAP, continuous positive airway pressure; ECMO, extracorporeal membrane oxygenation;
ICU, intensive care unit; CI, confidence interval; NICU, neonatal intensive care unit;
PCR, polymerase chain reaction